Recent advances in the epidemiology, prevention and treatment of invasive fungal infections in neutropenic patients

REFERENCES

• Anaissie E., Bodey G.P. Fungal infections in patients with cancer. Pharmacotherapy 1990; 10: 1645–1695
   Web of Science ®Google Scholar
• Anaissie E., Bodey G.P., Gokoslan A., Hachem R., Rubin R. Azole therapy for trichopsoronosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clinical Infectious Diseases 1992; 15: 781–787
   PubMed Web of Science ®Google Scholar
• Anaissie E., Bodey G.P., Kantarjian H., David C., Barnett K., Bow E., Defelice R., Downs N., File T., Karam G., Potts D., Shelton M., Sugar A. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. American Journal of Medicine 1991; 91: 142–150
   PubMed Web of Science ®Google Scholar
• Anaissie E., Bodey G.P., Kantarjan H., Ro J., Vartivarian S.E., Hopfer R., May J., Rolston K. New spectrum of fungal infections in patients with cancer. Reviews of Infectious Diseases 1989; 11: 369–378
   PubMedGoogle Scholar
• Anaissie E., Kantarjian H., Jones P., Barlogie B., Luna M., Lopez-Berestein G., Bodey G.P. Fusarium: a newly recognized fungal pathogen in immunosuppressed patients. Cancer 1986; 57: 2141–2145
   PubMed Web of Science ®Google Scholar
• Anaissie E., Kantarjian H., Ro J., Hopfer R., Rolston K., Fainstein V., Bodey G. The emerging role of Fusarium infections in patients with cancer. Medicine 1988; 67: 77–83
   PubMed Web of Science ®Google Scholar
• Antman K.S., Griffin J.D., Elias A., Socinski M.A., Ryan L., Cannistra S.A., Oette D., Whitley M., Frei E., Schnipper L.E. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. New England Journal of Medicine 1988; 319: 593–598
   PubMed Web of Science ®Google Scholar
• Armstrong D. Problems in management of opportunistic fungal diseases. Reviews of Infectious Diseases 1989; 11(Suppl. 7)S1591–S1599
   PubMedGoogle Scholar
• Arnow P.M., Sadigh M., Costas C., Weil D., Chudy R. Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms. Journal of Infectious Diseases 1991; 164: 998–1002
   PubMed Web of Science ®Google Scholar
• Barloon T.J., Galvin J.R., Mori M., Stanford W., Gingrich R.D. High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific roentgenograms. Chest 1991; 99: 928–933
   PubMed Web of Science ®Google Scholar
• Beck-Sague C.M., Jarvis W.R., Banerjee S.N., Culver D., Gaynes P., The National Nosocomial Infection Surveillance System. Nosocomial fungal infections in U.S. hospitals, 1980–1990. Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA. American Society for Microbiology, Washington, DC 1990; 274–274, Abstract no. 1129
   Google Scholar
• Bille J., Edson R.S., Roberts G.D. Clinical evaluation of the lysis centrifugation blood culture system for the detection of fungemia and comparison with a conventional biphasis broth blood culture system. Journal of Clinical Microbiology 1984; 19: 126–128
   PubMed Web of Science ®Google Scholar
• Bodey G.P. Candidiasis in cancer patients. American Journal of Medicine 1984; 77(Suppl. 4D)13–19
   PubMed Web of Science ®Google Scholar
• Bodey G.P., Anaissie E.J. Chronic systemic candidiasis. European Journal of Clinical Microbiology & Infectious Diseases 1989; 8: 855–857
   PubMed Web of Science ®Google Scholar
• Bodey G.P., Anaissie E., Gutterman J., Vadhan-Raj S. Role of granulocyte-macrophage colony stimulating factor as adjuant therapy for fungal infections in patients with cancer. Clinical Infectious Diseases 1993; 17: 705–707
   PubMed Web of Science ®Google Scholar
• Bozzette S.A., Larsen R.A., Chiu J., Leal M.A.E., Jacobsen J., Rothman P., Robinson P., Gilbert G., McCutchan J.A., Tilles J., Leedom J.M., Richman D.D. A placebocontrolled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. New England Journal of Medicine 1991; 324: 580–584
   PubMed Web of Science ®Google Scholar
• Branch R.A. Prevention of amphotericin B-induced renal impairment: a review on the use of sodium supplementation. Archives of Internal Medicine 1988; 148: 2389–2394
   PubMed Web of Science ®Google Scholar
• Brandt S.J., Peters W.P., Atwater S.K., Kurtzberg G.J., Borowitz M.J., Jones R.B., Shpall E.J., Bast R.C., Gilbert C.J., Oette D.H. Effect of recombinant human granulocyte-macrophage colony stimulating factor on hematopoietic reconstitution after high doses of chemotherapy and autologous bone marrow transplantation. New England Journal of Medicine 1988; 318: 869–876
   PubMed Web of Science ®Google Scholar
• Brooks R.G. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Archives of Internal Medicine 1989; 149: 2226–2228
   PubMedGoogle Scholar
• Burch P.A., Karp J.E., Merz W.G., Kuhlman J.E., Fishman E.K. Favorable outcome of invasive aspergillosis in patients with acute leukemia. Journal of Clinical Oncology 1987; 5: 1985–1993
   PubMed Web of Science ®Google Scholar
• Chopra R., Blair S., Strang J., Cervi P., Patterson K.G., Goldstone A.H. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. Journal Antimicrobial Chemotherapy 1991; 28(Suppl. B)93–104
   PubMed Web of Science ®Google Scholar
• Commers J.R., Robichaud K.J., Pizzo P.A. New pulmonary infiltrates in granulocytopenic cancer patients being treated with antibiotics. Pediatric Infectious Disease Journal 1984; 3: 423–428
   Web of Science ®Google Scholar
• Crislip M.A., Edwards J.E. Candidiasis. Infectious Diseases Clinic of North America 1989; 3: 103–133
   PubMedGoogle Scholar
• Daly A.L., Velazquez L.A., Bradley S.F., Kaufmann C.A. Mucomycosis: association with deferoxamine therapy. American Journal of Medicine 1989; 87: 468–471
   PubMed Web of Science ®Google Scholar
• Dato V.M., Dajani A.S. Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatric Infectious Disease Journal 1990; 3: 309–314
   Web of Science ®Google Scholar
• Denning D.W., Stevens D.A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Reviews of Infectious Diseases 1990; 12: 1417–1201
   Google Scholar
• Denning D.W., Tucker R.M., Hanson L.H., Stevens D.A. Treatment of invasive aspergillosis with itraconazole. American Journal of Medicine 1989; 86: 791–800
   PubMed Web of Science ®Google Scholar
• Dick J.D., Rosenguard B., Merz W.G., Stuart R.K., Hutchins G.M., Saral R. Fatal disseminated candidiasis due to amphotericin B-resistant Candida guilliermondii. Annals of Internal Medicine 1985; 102: 78–68
   Web of Science ®Google Scholar
• Dixon D.M., Walsh T.J., Merz W.G., McGinnis M.R. Infections due to Xylohypha bantiana (Cladosporium trichoides). Reviews of Infectious Diseases 1989; 11: 515–525
   PubMedGoogle Scholar
• EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. American Journal of Medicine 1989; 86: 668–672
   PubMed Web of Science ®Google Scholar
• Eppes S.C., Troutman J.L., Gutman L.T. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatric Infectious Disease Journal 1989; 8: 99–104
   PubMed Web of Science ®Google Scholar
• Evans T.G., Mayer J., Cohen S., Classen D., Carroll K. Fluconazole failure in the treatment of invasive mycoses. Journal of Infectious Diseases 1991; 164: 1232–1235
   PubMed Web of Science ®Google Scholar
• Fader R.C., McGinnis M.R. Infections caused by dematiaceous fungi: chromoblastomycosis and phaeohyphomycosis. Infectious Disease Clinics of North America 1988; 2: 925–938
   PubMedGoogle Scholar
• Girmenia C., Arcese W., Micozzi A., Martino P., Bianco P., Morace G. Onychomycosis as a possible origin of disseminated Fusarium solani infection in patients with severe asplastic anemia. Clinical Infectious Diseases 1992; 14: 1167–1167
   PubMed Web of Science ®Google Scholar
• Goodman J.L., Winston D.J., Greenfield R.A. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine 1992; 326: 845–851
   PubMed Web of Science ®Google Scholar
• Johnston P.G., Lee J., Domanski M., Dressler F., Tucker E., Rothenberg M., Cunnion R.E., Pizzo P.A., Walsh T.J. Late recurrent Candida endocarditis. Chest 1991; 99: 1531–1533
   PubMed Web of Science ®Google Scholar
• Kahn F.W., Jones J.M., England D.M. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. American Journal of Clinical Pathology 1986; 86: 518–523
   PubMed Web of Science ®Google Scholar
• Kan V.L., Bennett J.E., Amantea M.A., Smolskis M.C., McManus E., Grasela D.M., Sherman J.W. Comparative safety, tolerance, and pharmacokinetics of amphotericin B lipid complex and amphotericin B desoxycholate in healthy male volunteers. Journal of Infectious Diseases 1991; 164: 418–421
   PubMed Web of Science ®Google Scholar
• Karp J.E., Burch P.A., Merz W.G. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. American Journal of Medicine 1988; 85: 203–206
   PubMed Web of Science ®Google Scholar
• Kauffman C.A., Bradley S.F., Ross S.C., Weber D.R. Hepatosplenic candidiasis: Successful treatment with fluconazole. American Journal of Medicine 1991; 91: 137–141
   PubMed Web of Science ®Google Scholar
• Klotz S.A. Malassezia furfur. Infectious Disease Clinics of North America 1989; 3: 53–64
   PubMedGoogle Scholar
• Knoper S.R., Galgiani J.N. Coccidioidomycosis. Infectious Disease Clinics of North America 1988; 2: 861–875
   PubMedGoogle Scholar
• Kuhlman J.E., Fishman E.K., Burch P.A., Karp J.E., Zerhouni E.A., Siegelman S.S. Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management. Chest 1987; 92: 95–99
   PubMed Web of Science ®Google Scholar
• Lecciones J.A., Lee J.W., Navarro E.E., Witebsky F.G., Marshall D., Steinberg S.M., Pizzo P.A., Walsh T.J. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clinical Infectious Diseases 1992; 14: 875–883
   PubMed Web of Science ®Google Scholar
• Lee J., Allende M., Amantea M., Francis P., Peter J., Thomas V., Francesconi A., Lyman C., Schaufele R., Bacher J.R., Pizzo P.A., Walsh T. (1991) Pharmacokinetics and efficacy of amphotericin B lipid complex (ABLC) against chronic disseminated candidiasis in rabbits. Program and Abstracts of the 31st Interscience Conference on Antimicrobial Agents & Chemotherapy, Chicago, IL, 1991. American Society for Microbiology, Washington, DC, 195–195, Abstract 579
   Google Scholar
• Lee J., Allende M., Dollenberg H., Garrett K., Berenguer J., Francesconi A., Sein T., Lyman C., Francis P., Pizzo P., Walsh T. (1992) Reticuloendothelial loading with amphotericin B lipid complex (ABLC)—a novel pharmocodynamic approach to treatment of experimental hepatosplenic candidiasis (HSC). Program and Abstracts of the Thirty-second Interscience Conference on Antimicrobial Agents & Chemotherapy, Anaheim, CA, 1992. American Society for Microbiology, Washington, DC, 139–139, Abstract 172
   Google Scholar
• Lee J.W., Seibel N.L., Amantea M., Whitcomb P., Pizzo P.A., Walsh T.J. Safety, tolerance, and pharmacokinetics of fluconazole in children with neoplastic diseases. Journal of Pediatrics 1992; 120: 987–993
   PubMed Web of Science ®Google Scholar
• Lee J.W., Walsh T.J. Clinical pharmacology of systemic antifungal agents. Clinical Advances in the Treatment of Fungal Infections 1991; 2: 6–9
   Google Scholar
• Leggiadro R.J., Barrett F.F., Hughes W.T. Extrapulmonary cryptococcosis in immunocompromised infants and children. Pediatric Infectious Disease Journal 1992; 11: 43–47
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Bodey G.P., Fainstein V.N., Keating M., Frankel L.S., Zeluff B., Gentry L., Mehta K. Treatment of systemic fungal infections with liposomal amphotericin B. Archives of Internal Medicine 1989; 149: 2533–2536
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Bodey G.P., Frankel L.S., Mehta K. Treatment of hepatosplenic candidiasis with liposomal amphotericin B. Journal of Clinical Oncology 1987; 5: 310–317
   PubMed Web of Science ®Google Scholar
• Lyman C.A., Walsh T.J. Systemically administered antifungal agents: a review of their clinical pharmacology and therapeutic applications. Drugs. 1992; 44: 9–35
   PubMed Web of Science ®Google Scholar
• Martino P., Gastaldi R., Raccah R., Girmenia C. Clinical patterns of Fusarium infection in immunocompromised patients. Journal of Infection 1994; 28(Suppl. 1)7–15
   PubMedGoogle Scholar
• Martino P., Girmenia C., Micozzi A. Fungemia in patients with leukemia. American Journal of Medical Sciences 1993; 306: 225–232
   PubMed Web of Science ®Google Scholar
• Martino P., Girmenia C., Venditti M., Inicotti A., Santilli S., Burglo V.L., Mandelli A. Candida colonization and systemic infection in neutropenic patients. Cancer 1989; 64: 2030–2034
   PubMed Web of Science ®Google Scholar
• Martino P., Venditti M., Micozzi A. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Reviews of Infectious Diseases 1990; 12: 6570–6582
   Google Scholar
• Melcher G.P., Reed K.D., Rinaldi M.G., Lee J.W., Pizzo P.A., Walsh T.J. Demonstration of a cell wall antigen cross-reacting with cryptococcal polysaccharide in experimental disseminated trichosporonosis. Journal of Clinical Microbiology 1991; 29: 192–196
   PubMed Web of Science ®Google Scholar
• Merz W.G. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. Journal of Clinical Microbiology 1984; 20: 1194–1195
   PubMed Web of Science ®Google Scholar
• Merz W.G., Hoagland M., Jett-Coheen M., Junkins J.M., Hood A.H. Diagnosis and successful treatment of fusariosis in the compromised host. Journal of Infectious Diseases 1988; 158: 1046–1055
   PubMed Web of Science ®Google Scholar
• Meunier F., Aoun M., Gerard M. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole. Reviews of Infectious Diseases 1990; 12(Suppl. 3)S364–S368
   PubMedGoogle Scholar
• Meyer R.D., Rosen P., Armstrong D. Phycomycosis complicating leukemia and lymphoma. Annals of Internal Medicine 1972; 77: 871–879
   PubMed Web of Science ®Google Scholar
• Meyer R.D., Young L.S., Armstrong D. Aspergillosis complicating neoplastic disease. American Journal of Medicine 1973; 54: 6–15
   PubMed Web of Science ®Google Scholar
• Navarro E., Lecciones J., Witebsky F., Marshall D., Francis P., Schaufele R., Pizzo P.A. Invasive aspergillosis developing during empirical antifungal therapy. Abstracts of the 90th Annual Meeting of the American Society for Microbiology, Washington DC, 1990; 420–420, Abstract F71
   Google Scholar
• Neumanaitis J., Meyers J.D., Buckner C.D., Shannon-Dorcy K., Mori M., Shulman H., Bianco J.A., Higano C.S., Groves E., Storb R., Hansen J., Applehaum F.R., Singer J.W. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood 1991; 78: 907–913
   PubMed Web of Science ®Google Scholar
• Pannuti C.S., Gingrich R.D., Pfaller M.A., Wenzel R.P. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. Journal of Clinical Oncology 1991; 9: 77–84
   PubMed Web of Science ®Google Scholar
• Panos R.J., Barr L.F., Walsh T.J., Silverman H.J. Factors associated with fatal hemoptysis in cancer patients. Chest 1988; 94: 1008–1013
   PubMed Web of Science ®Google Scholar
• Pizzo P.A. After empiric therapy: what to do until the granulocyte comes back. Reviews of Infectious Diseases 1987; 9: 214–219
   PubMedGoogle Scholar
• Pizzo P.A., Hathorn J.W., Hiemenz J., Browne M., Commers J., Cotton D., Gress J., Longo D., Marshall D., McKnight J., Rubin M., Skelton J., Thaler M., Wesley R. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. New England Journal of Medicine 1986; 315: 552–558
   PubMed Web of Science ®Google Scholar
• Pizzo P.A., Robichaud K.J., Gill F., Witebsky F.G. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. American Journal of Medicine 1982; 72: 101–111
   PubMed Web of Science ®Google Scholar
• Pizzo P.A., Rubin M., Freifeld A., Walsh T.J. The child with cancer and infection. I: Empiric therapy for fever and neutropenia, and preventive strategies. Journal of Pediatrics 1991; 119: 679–694
   PubMed Web of Science ®Google Scholar
• Pizzo P.A., Rubin M., Freifeld A., Walsh T.J. The child with cancer and infection. II: Nonbacterial infections. Journal of Pediatrics 1991; 119: 845–857
   PubMed Web of Science ®Google Scholar
• Richet H.M., Andremont A., Tancrede C., Pico J.L., Jarvis W.R. Risk factors for candidemia in patients with acute lymphocytic leukemia. Reviews of Infectious Diseases 1991; 13: 211–215
   PubMedGoogle Scholar
• Rinaldi M.G. Zygomycosis. Infectious Disease Clinics of North America 1989; 3: 19–41
   PubMed Web of Science ®Google Scholar
• Ringden O., Meunier F., Tollemar J., Ricci P., Tura S., Kuse E., Vivani M.A., Gorin N.C., Klastersky J., Fenaux P., Prentice H.G., Ksionski G. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. Journal of Antimicrobial Chemotherapy 1991; 28(Suppl. B)73–82
   PubMed Web of Science ®Google Scholar
• Robertson M.J., Larson R.A. Recurrent fungal pneumonias in patients with acute non-lymphocytic leukemia undergoing multiple courses of intensive chemotherapy. American Journal of Medicine 1988; 84: 233–239
   PubMed Web of Science ®Google Scholar
• Rousey S.P., Russler S., Gottlieb M., Ash R.C. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. American Journal of Medicine 1991; 91: 484–492
   PubMed Web of Science ®Google Scholar
• Roy J.B., Geyer J.R., Mohr J.A. Urinary tract candidiasis. An update. Urology 1984; 23: 533–537
   PubMed Web of Science ®Google Scholar
• Saag M.S., Dismukes W.E. Azole antifungal agents: emphasis on new triazoles. Antimicrobial Agents and Chemotherapy 1988; 32: 1–8
   PubMed Web of Science ®Google Scholar
• Saito H., Anaissie E.J., Morice R.C., Dekmezian R., Bodey G.P. Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia. Chest 1988; 94: 745–749
   PubMed Web of Science ®Google Scholar
• Sandford G.R., Merz W.G., Wingard J.J., Charache P., Saral R. The value of fungal surveillance cultures as predictors of systemic fungal infections. Journal of Infectious Diseases 1980; 142: 503–509
   PubMed Web of Science ®Google Scholar
• Sobel J.D. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clinical Infectious Diseases 1992; 14(Suppl. 1)S148–S153
   PubMed Web of Science ®Google Scholar
• Souza L.M., Boone T.C., Gabrilove J., Lai P.H., Zsebo K.M., Murdock D.C., Chazin V.R., Bruszewski J., Lu H., Chen K.K., Barendt J., Platzer E., Moore M.A.S., Mertelsmann R., Welte K. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986; 232: 61–65
   PubMed Web of Science ®Google Scholar
• Thaler M., Pastakia B., Shawker T.H., O'Leary T., Pizzo P.A. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Annals of Internal Medicine 1988; 108: 88–100
   PubMed Web of Science ®Google Scholar
• Treger T.R., Visscher D.W., Bartlett M.S., Smith J.W. Diagnosis of pulmonary infection caused by Aspergillus: Usefulness of respiratory cultures. Journal of Infectious Diseases 1985; 152: 572–576
   PubMed Web of Science ®Google Scholar
• Vreugdenhil G., Van Dijke B.J., Donnelly J.P., Novakova I.R.O., Raemaekers J.M.M., Hoogkamp-Korstanje M.A.A., De Pauw B.E. Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematological malignancies and intensive chemotherapy. A double blind, placebo controlled study. Leukemia and Lymphoma 1993; 11: 353–358
   PubMed Web of Science ®Google Scholar
• Walsh T.J. Trichosporonosis. Infectious Disease Clinics of North America 1989; 3: 43–52
   PubMedGoogle Scholar
• Walsh T.J. Invasive pulmonary aspergillosis in patients with neoplastic diseases. Seminars in Respiratory Infections 1990; 5: 111–122
   PubMedGoogle Scholar
• Walsh T.J., Belitsos N.J., Hamilton S.R. Bacterial esophagitis in immunocompromised patients. Archives of Internal Medicine 1986; 146: 1345–1348
   PubMedGoogle Scholar
• Walsh T.J., Bustamante C.I., Vlahov D., Standiford H.C. Candidal suppurative peripheral thrombophlebitis: recognition, prevention and management. Infection Control and Hospital Epidemiology 1986; 7: 16–22
   Web of Science ®Google Scholar
• Walsh T.J., Bulkley B.H. Aspergillus pericarditis: Clinical and pathologic features in the immunocompromised patient. Cancer 1982; 49: 48–54
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Caplan L.R., Hier D.B. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Annals of Neurology 1985; 18: 574–582
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Catchatourian R., Cohen H. Disseminated histoplasmosis complicating bone marrow transplantation. American Journal of Clinical Pathology 1983; 79: 509–511
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Dixon D.M. Nosocomial aspergillosis environmental microbiology, hospital epidemiology, diagnosis, and treatment. European Journal of Epidemiology 1989; 5: 131–142
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Gray W.C. Candida epioglottitis in immunocompromised patients. Chest 1987; 91: 482–485
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Hamilton S.R., Belitsos N. Esophageal candidiasis. Managing an increasingly prevalent infection. Postgraduate Medicine 1988; 84: 193–205
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Hier D.B., Caplan L.R. Fungal infections of the central nervous system: comparative analysis of risk factors and clinical signs in 57 patients. Neurology 1985; 35: 1654–1657
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Lee J., Aoki S., Mechinaud F., Bacher J., Lecciones J., Thomas V., Rubin M., Pizzo P.A. Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts. Reviews of Infectious Diseases 1990; 12(Suppl. 3)S307–S317
   PubMedGoogle Scholar
• Walsh T.J., Lee J., Lecciones J., Rubin M., Butler K., Francis P., Weinberger M., Roilides E., Marshall D., Gress J., Pizzo P.A. Empirical amphotericin B in febrile granulocytopenic patients. Reviews of Infectious Diseases 1991; 13: 496–503
   PubMedGoogle Scholar
• Walsh T.J., Lee J.W., Pizzo P.A. Immunodiagnosis of invasive candidiasis in patients with neoplastic diseases. New Strategies in Fungal Disease, J.E. Bennett, R.J. Hay, P.K. Peterson. Churchill-Livingstone, London 1992; 227–242, In
   Google Scholar
• Walsh T.J., Melcher G.P., Rinaldi M.G., Lecciones J., McGough D.A., Kelly P., Lee J., Callender D., Rubin M., Pizzo P.A. Trichosporon beigelii: an emerging pathogen resistant to amphotericin B. Journal of Clinical Microbiology 1990; 28: 1616–1622
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Merz W.G. Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. American Journal of Clinical Pathology 1986; 85: 498–502
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Pizzo P.A. Treatment of systemic fungal infections: recent progress and current problems. European Journal of Clinical Microbiology & Infectious Diseases 1988; 7: 460–475
   PubMed Web of Science ®Google Scholar
• Walsh T.J., Rubin M., Hathorn J., Gress J., Thaler M., Skelton J., McKnight J., Browne M., Marshall D., Cotton D., Hiemenz J., Longo D., Wesley R., Pizzo P.A. Amphotericin B versus high-dose ketoconazole for empirical antifungal therapy among febrile granulocytopenic cancer patients: a prospective, randomized study. Archives of Internal Medicine 1991; 151: 765–770
   PubMed Web of Science ®Google Scholar
• Weisbart R.H., Gasson J.C., Golde D.W. Colony-stimulating factors and neutrophils. Colony stimulating-factors and host defense. Annals of Internal Medicine 1989; 110: 297–298
   PubMed Web of Science ®Google Scholar
• Wey S.B., Mori M., Pfaller M.A., Woolson R.F., Wenzel R.P. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Archives of Internal Medicine 1988; 48: 2642–2645
   Google Scholar
• Wey S.B., Mori M., Pfaller M.A., Woolson R.F., Wenzel R.P. Risk factors for hospital-acquired candidemia: A matched case-control study. Archives of Internal Medicine 1989; 149: 2349–2353
   PubMed Web of Science ®Google Scholar
• Wheat L.J. Histoplasmosis. Infectious Disease Clinics of North America 1988; 2: 841–859
   PubMedGoogle Scholar
• Wiley J.M., Smith N., Leventhal B.G., Graham M.L., Strauss L.C., Hurwitz C.A., Modlin J., Mellits D., Baumgardner R., Corden B.J., Ovin C.I. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. Journal of Clinical Oncology 1990; 8: 280–286
   PubMed Web of Science ®Google Scholar
• Wingard J.R., Merz W.G., Rinaldi M.G., Johnson T.R., Karp J.E., Saral R. Increase in Candida krusei infections among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 1991; 325: 1274–1277
   PubMed Web of Science ®Google Scholar
• Wingard J.R., Merz W.G., Saral W.R. Candida tropicalis: a major pathogen in immunocompromised patients. Annals of Internal Medicine 1979; 91: 539–543
   PubMed Web of Science ®Google Scholar
• Winston D.W., Chandrasekar P.H., Lazarus H.M. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double blind, multicenter trial. Annals of Internal Medicine 1993; 118: 495–503
   PubMed Web of Science ®Google Scholar
• Working Party of the British Society for Antimicrobial Chemotherapy. Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. Journal of Antimicrobial Chemotherapy 1993; 32: 5–21
   PubMed Web of Science ®Google Scholar
• Yu V.L., Muder R.R., Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. American Journal of Medicine 1986; 81: 249–254
   PubMed Web of Science ®Google Scholar